SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 369 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $458 | -30.0% | 2,896 | -42.7% | 0.03% | -38.5% |
Q1 2024 | $654 | +2.2% | 5,052 | -23.9% | 0.05% | -3.7% |
Q4 2023 | $640 | -22.5% | 6,641 | -2.6% | 0.05% | -23.9% |
Q3 2023 | $826 | +3.9% | 6,815 | +11.1% | 0.07% | -28.3% |
Q4 2022 | $795 | -99.9% | 6,134 | -15.6% | 0.10% | -7.5% |
Q3 2022 | $804,000 | +132.4% | 7,270 | +57.5% | 0.11% | +105.8% |
Q2 2022 | $346,000 | -24.1% | 4,617 | -20.8% | 0.05% | -14.8% |
Q1 2022 | $456,000 | -37.0% | 5,832 | -27.4% | 0.06% | -33.0% |
Q4 2021 | $724,000 | +173.2% | 8,037 | +136.2% | 0.09% | +203.3% |
Q2 2021 | $265,000 | +2.3% | 3,403 | +123.9% | 0.03% | -28.6% |
Q4 2020 | $259,000 | -41.4% | 1,520 | -51.7% | 0.04% | -43.2% |
Q3 2020 | $442,000 | -15.6% | 3,144 | -54.8% | 0.07% | +4.2% |
Q3 2019 | $524,000 | +69.0% | 6,961 | +168.0% | 0.07% | +129.0% |
Q1 2019 | $310,000 | +54.2% | 2,597 | -58.4% | 0.03% | +210.0% |
Q3 2015 | $201,000 | – | 6,245 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |